Found: 111
Select item for more details and to access through your institution.
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 3872, doi. 10.1245/s10434-024-14999-2
- By:
- Publication type:
- Article
Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 6, p. 662, doi. 10.1111/iju.15434
- By:
- Publication type:
- Article
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone‐sensitive prostate cancer; KYUCOG‐1401.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 4, p. 362, doi. 10.1111/iju.15371
- By:
- Publication type:
- Article
Bone‐modifying agents are protective for symptomatic skeletal events in Radium‐223 treatment.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 11, p. 1029, doi. 10.1111/iju.15259
- By:
- Publication type:
- Article
Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2325, doi. 10.1002/cam4.5057
- By:
- Publication type:
- Article
Effectiveness and safety of radium‐223 dichloride in patients with castration‐resistant prostate cancer and bone metastases in real‐world practice: A multi‐institutional study.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 2, p. 139, doi. 10.1111/iju.15078
- By:
- Publication type:
- Article
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 11, p. 1271, doi. 10.1111/iju.14977
- By:
- Publication type:
- Article
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 10, p. 1632, doi. 10.1007/s10147-022-02221-w
- By:
- Publication type:
- Article
Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 10, p. 1147, doi. 10.1111/iju.14938
- By:
- Publication type:
- Article
Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 9, p. 1056, doi. 10.1093/jjco/hyac092
- By:
- Publication type:
- Article
Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 7, p. 2386, doi. 10.1111/cas.15383
- By:
- Publication type:
- Article
Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities.
- Published in:
- Cancer Science, 2022, v. 113, n. 6, p. 2144, doi. 10.1111/cas.15309
- By:
- Publication type:
- Article
Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 5, p. 398, doi. 10.1111/iju.14793
- By:
- Publication type:
- Article
Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 418, doi. 10.1007/s10147-021-02070-z
- By:
- Publication type:
- Article
Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study.
- Published in:
- BJUI Compass, 2022, v. 3, n. 1, p. 26, doi. 10.1002/bco2.103
- By:
- Publication type:
- Article
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 194, doi. 10.1007/s10147-021-02041-4
- By:
- Publication type:
- Article
Predictive factors of survival outcomes in first‐line therapy for metastatic castration‐resistant prostate cancer.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 1, p. 26, doi. 10.1111/iju.14702
- By:
- Publication type:
- Article
Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab.
- Published in:
- International Journal of Urology, 2021, v. 28, n. 12, p. 1261, doi. 10.1111/iju.14686
- By:
- Publication type:
- Article
Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3616, doi. 10.1111/cas.15038
- By:
- Publication type:
- Article
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study.
- Published in:
- International Journal of Urology, 2021, v. 28, n. 7, p. 765, doi. 10.1111/iju.14568
- By:
- Publication type:
- Article
Prognostic impact of prior local therapy in castration-resistant prostate cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1142, doi. 10.1093/jjco/hyab019
- By:
- Publication type:
- Article
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 7, p. 2491, doi. 10.1007/s00345-020-03494-4
- By:
- Publication type:
- Article
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 10, p. 3188, doi. 10.1002/cam4.3863
- By:
- Publication type:
- Article
Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 10, p. 3240, doi. 10.1002/cam4.3895
- By:
- Publication type:
- Article
External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 810, doi. 10.1093/jjco/hyaa264
- By:
- Publication type:
- Article
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1524, doi. 10.1111/cas.14722
- By:
- Publication type:
- Article
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 12, p. 2107, doi. 10.1007/s10147-020-01761-3
- By:
- Publication type:
- Article
Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide.
- Published in:
- International Journal of Urology, 2020, v. 27, n. 12, p. 1109, doi. 10.1111/iju.14366
- By:
- Publication type:
- Article
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer.
- Published in:
- BJUI Compass, 2020, v. 1, n. 5, p. 165, doi. 10.1002/bco2.35
- By:
- Publication type:
- Article
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external‐beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open‐label, randomized, phase 3 trial
- Published in:
- 2020
- By:
- Publication type:
- journal article
Perioperative therapies for urological cancers.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 4, p. 357, doi. 10.1093/jjco/hyaa013
- By:
- Publication type:
- Article
Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 557, doi. 10.1007/s10147-018-01389-4
- By:
- Publication type:
- Article
Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 8, n. 6, p. 785, doi. 10.3892/mco.2018.1602
- By:
- Publication type:
- Article
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 173, doi. 10.1007/s10147-017-1176-0
- By:
- Publication type:
- Article
Demographics, management and treatment outcomes of benign and malignant retroperitoneal tumors in Japan.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 1, p. 61, doi. 10.1111/iju.13469
- By:
- Publication type:
- Article
An In Vitro Study of a New Device: Evaluation of Novel Wide-Angle Lens Flexible Cystoscope Using Phantom Bladder Model.
- Published in:
- Journal of Endourology, 2017, v. 31, n. 10, p. 1073, doi. 10.1089/end.2017.0371
- By:
- Publication type:
- Article
Aldehyde Dehydrogenase 2 Polymorphism Is a Predictor of Smoking Cessation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan.
- Published in:
- Cancer Science, 2017, v. 108, n. 8, p. 1673, doi. 10.1111/cas.13293
- By:
- Publication type:
- Article
The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 5, p. 1443, doi. 10.1245/s10434-016-5705-2
- By:
- Publication type:
- Article
Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 5, p. 453, doi. 10.1093/jjco/hyx013
- By:
- Publication type:
- Article
FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.
- Published in:
- Prostate, 2017, v. 77, n. 2, p. 145, doi. 10.1002/pros.23254
- By:
- Publication type:
- Article
Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare.
- Published in:
- BJU International, 2016, v. 118, n. 6, p. 880, doi. 10.1111/bju.13483
- By:
- Publication type:
- Article
Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 10, p. 952, doi. 10.1093/jjco/hyw098
- By:
- Publication type:
- Article
Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores.
- Published in:
- MAGMA: Magnetic Resonance Materials in Physics, Biology & Medicine, 2016, v. 29, n. 4, p. 671, doi. 10.1007/s10334-016-0537-4
- By:
- Publication type:
- Article
Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2.
- Published in:
- Cancer Science, 2016, v. 107, n. 7, p. 1022, doi. 10.1111/cas.12948
- By:
- Publication type:
- Article
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
- Published in:
- 2016
- By:
- Publication type:
- journal article